These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1111790)

  • 1. Bromocriptine treatment of acromegaly.
    Thorner MO; Chait A; Aitken M; Benker G; Bloom SR; Mortimer CH; Sanders P; Mason AS; Besser GM
    Br Med J; 1975 Feb; 1(5953):299-303. PubMed ID: 1111790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of long term bromocriptine treatment on glucose intolerance in acromegaly.
    Chiba T; Chihara K; Minamitani N; Goto B; Kadowaki S; Taminato T; Matsukura S; Fujita T
    Horm Metab Res; 1982 Feb; 14(2):57-61. PubMed ID: 7040191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bromocriptine acute effect on insulin, glucagon and growth hormone levels in acromegalic patients.
    Fedele D; Molinari M; Meneghel A; Valerio A; Muggeo M; Tiengo A
    J Endocrinol Invest; 1980; 3(2):149-53. PubMed ID: 6993548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reappraisal of bromocriptine treatment for acromegaly.
    Maneschi F
    Horm Res; 1980; 12(4):191-205. PubMed ID: 7390405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of bromocriptine on serum hormones in acromegaly.
    Carlson HE; Levin SR; Braunstein GD; Spencer EM; Wilson SE; Hershman JM
    Horm Res; 1984; 19(3):142-52. PubMed ID: 6425186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ergot alkaloids on growth hormone and prolactin secretion in humans.
    Silvestrini F; Liuzzi A; Chiodini PG
    Pharmacology; 1978; 16 Suppl 1():78-87. PubMed ID: 643905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of acromegaly with bromocriptine.
    Wang C; Chan V; Yeung RT
    Aust N Z J Med; 1979 Jun; 9(3):225-32. PubMed ID: 288387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experiences with bromocriptine treatment in acromegaly--a preliminary report.
    Nilsson A
    Acta Endocrinol Suppl (Copenh); 1978; 216():217-24. PubMed ID: 274038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in circulating somatomedin-C levels in bromocriptine-treated acromegaly.
    Wass JA; Clemmons DR; Underwood LE; Barrow I; Besser GM; Van Wyk JJ
    Clin Endocrinol (Oxf); 1982 Oct; 17(4):369-77. PubMed ID: 6890417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of acromegaly using bromocriptine].
    Köbberling J; Schwinn G; Dirks H
    Dtsch Med Wochenschr; 1975 Jul; 100(29):1540-2. PubMed ID: 1149634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term treatment of acromegaly with bromocriptine.
    Eskildsen PG; Svendsen PA; Vang L; Nerup J
    Acta Endocrinol (Copenh); 1978 Apr; 87(4):687-700. PubMed ID: 417539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bromocriptine reduces growth hormone in acromegaly.
    Bell PM; Atkinson AB; Hadden DR; Kennedy L; Leslie H; Merrett JD; Sheridan B
    Arch Intern Med; 1986 Jun; 146(6):1145-9. PubMed ID: 3718102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bromocriptine therapy in acromegaly. A long-term review of 35 cases.
    Sachdev Y; Gopal K; Garg VK
    Postgrad Med J; 1981 Apr; 57(666):210-6. PubMed ID: 7027229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term treatment with 2-Br-alpha-ergocryptine in acromegaly.
    Belforte L; Camanni F; Chiodini PG; Liuzzi A; Massara F; Molinatti GM; Müller EE; Silvestrini F
    Acta Endocrinol (Copenh); 1977 Jun; 85(2):235-48. PubMed ID: 405832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term infusion of growth hormone release inhibiting hormone in acromegaly: effects on pituitary and pancreatic hormones.
    Besser GM; Mortimer CH; McNeilly AS; Thorner MO; Batistoni GA; Bloom SR; Kastrup KW; Hanssen KF; Hall R; Coy DH; Kastin AJ; Schally AV
    Br Med J; 1974 Dec; 4(5945):622-7. PubMed ID: 4374289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bromocriptine treatment in acromegaly: clinical and biochemical effects.
    Halse J; Haugen HN; Bohmer T
    Acta Endocrinol (Copenh); 1977 Nov; 86(3):464-72. PubMed ID: 335755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term treatment of acromegaly with Sandostatin (SMS 201-995). Normalization of most anomalous growth hormone responses.
    Pieters GF; van Liessum PA; Smals AG; van Gennep JA; Benraad TJ; Kloppenborg PW
    Acta Endocrinol Suppl (Copenh); 1987; 286():9-18. PubMed ID: 2892339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic bromocriptine treatment and glucose intolerance in acromegaly.
    Popović V; Micić D; Nesović M; Djordjević P; Mićić J; Djurić DS
    Exp Clin Endocrinol; 1985 Jun; 85(3):351-7. PubMed ID: 3899685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bromocriptine and glucose tolerance in acromegalics.
    Dolecek R; Kubis M; Sajnar J; Závada M
    Pharmatherapeutica; 1982; 3(2):100-6. PubMed ID: 7048336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bromocriptine therapy in eleven patients with acromegaly.
    Lundin L; Ljunghall S; Wide L; Boström H
    Acta Endocrinol Suppl (Copenh); 1978; 216():207-16. PubMed ID: 347863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.